AVITA Medical vs SANUWAVE Health
RCEL and SNWV side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RCEL and SNWV compare
AVITA Medical is the larger company, worth 30 times as much as SANUWAVE Health ($471M against $15.6M).
SANUWAVE Health grew revenue faster over the last twelve months (12.7% versus 1.00% for AVITA Medical).
SANUWAVE Health keeps more of each dollar of sales as profit, with a net margin of 34.7% compared with −57.0% at AVITA Medical.
SANUWAVE Health scores higher on the StockData Score (10 against 3 for AVITA Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RCEL | SNWV |
|---|---|---|
| Size and price | ||
| Market cap | $471M | $15.6M |
| Share price | $15.22 | $1.81 |
| Change, 1 year | 307% | −94.6% |
| Change, 5 years | 7.9% | 1292% |
| Beta (5Y) | 2.00 | 3.09 |
| Employees | 226 | 55 |
| StockData Score | ||
| Total score | 3 | 10 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 1 | 2 (better) |
| Health score | 0 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 6.2× | 0.4× (better) |
| P/B | – | 5.6× |
| EV/EBITDA | – | 2.4× |
| P/FCF | – | 3.7× |
| FCF yield | −5.2% | 27.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.00% | 12.7% (better) |
| Revenue growth, 5Y average | 67.2% (better) | 61.1% |
| Profitability | ||
| Gross margin | 81.6% (better) | 76.3% |
| Operating margin | −46.6% | 3.4% (better) |
| Net margin | −57.0% | 34.7% (better) |
| FCF margin | −32.5% | 9.6% (better) |
| Return on invested capital | −261% | – |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −6.5× | – |
| Current ratio | 0.41 | 1.28 (better) |
| Altman Z-score | −10.63 | −7.58 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 15.9% | 37.3% |
| Held by insiders | 2.7% | – |
| Insider net buying, 12 months | $235K (better) | −$11.6M |
Go deeper
- RCEL stock overview
- RCEL income statement
- RCEL valuation and score
- SNWV stock overview
- SNWV income statement
- SNWV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.